These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

224 related items for PubMed ID: 10400010

  • 1. Comparison of dual-chamber pacing versus septal myectomy for the treatment of patients with hypertrophic obstructive cardiomyopathy: a comparison of objective hemodynamic and exercise end points.
    Ommen SR, Nishimura RA, Squires RW, Schaff HV, Danielson GK, Tajik AJ.
    J Am Coll Cardiol; 1999 Jul; 34(1):191-6. PubMed ID: 10400010
    [Abstract] [Full Text] [Related]

  • 2. [Comparison of dual-chamber pacing versus septal myectomy for the treatment of patients with hypertrophic obstructive cardiomyopathy. A comparison of objective hemodynamic and exercise end points].
    Primo J, Tajik AJ.
    Rev Port Cardiol; 1999 Nov; 18(11):1079-81. PubMed ID: 10608168
    [No Abstract] [Full Text] [Related]

  • 3. Very late effects of dual chamber pacing therapy for obstructive hypertrophic cardiomyopathy.
    Lucon A, Palud L, Pavin D, Donal E, Behar N, Leclercq C, Mabo P, Daubert JC.
    Arch Cardiovasc Dis; 2013 Nov; 106(6-7):373-81. PubMed ID: 23806305
    [Abstract] [Full Text] [Related]

  • 4. Dual-chamber pacing for hypertrophic cardiomyopathy: a randomized, double-blind, crossover trial.
    Nishimura RA, Trusty JM, Hayes DL, Ilstrup DM, Larson DR, Hayes SN, Allison TG, Tajik AJ.
    J Am Coll Cardiol; 1997 Feb; 29(2):435-41. PubMed ID: 9015001
    [Abstract] [Full Text] [Related]

  • 5. Long-term results of dual-chamber (DDD) pacing in obstructive hypertrophic cardiomyopathy. Evidence for progressive symptomatic and hemodynamic improvement and reduction of left ventricular hypertrophy.
    Fananapazir L, Epstein ND, Curiel RV, Panza JA, Tripodi D, McAreavey D.
    Circulation; 1994 Dec; 90(6):2731-42. PubMed ID: 7994815
    [Abstract] [Full Text] [Related]

  • 6. Comparison of ethanol septal reduction therapy with surgical myectomy for the treatment of hypertrophic obstructive cardiomyopathy.
    Nagueh SF, Ommen SR, Lakkis NM, Killip D, Zoghbi WA, Schaff HV, Danielson GK, Quiñones MA, Tajik AJ, Spencer WH.
    J Am Coll Cardiol; 2001 Nov 15; 38(6):1701-6. PubMed ID: 11704383
    [Abstract] [Full Text] [Related]

  • 7. Impact of dual-chamber permanent pacing in patients with obstructive hypertrophic cardiomyopathy with symptoms refractory to verapamil and beta-adrenergic blocker therapy.
    Fananapazir L, Cannon RO, Tripodi D, Panza JA.
    Circulation; 1992 Jun 15; 85(6):2149-61. PubMed ID: 1350522
    [Abstract] [Full Text] [Related]

  • 8. Comparison of dual-chamber pacing with nonsurgical septal reduction effect in patients with hypertrophic obstructive cardiomyopathy.
    Dimitrow PP, Podolec P, Grodecki J, Płazak W, Dudek D, Pieniazek P, Bacior B, Legutko J, Olszowska M, Kostkiewicz M, Kawecka-Jaszcz K, Tracz W, Dubiel JS.
    Int J Cardiol; 2004 Mar 15; 94(1):31-4. PubMed ID: 14996471
    [Abstract] [Full Text] [Related]

  • 9. Is surgery the gold standard in the treatment of obstructive hypertrophic cardiomyopathy?
    Knyshov G, Lazoryshynets V, Rudenko K, Kravchuk B, Beshlyaga V, Zalevsky V, Rasputnyak O, Batsak B.
    Interact Cardiovasc Thorac Surg; 2013 Jan 15; 16(1):5-9. PubMed ID: 23027595
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Assessment of permanent dual-chamber pacing as a treatment for drug-refractory symptomatic patients with obstructive hypertrophic cardiomyopathy. A randomized, double-blind, crossover study (M-PATHY).
    Maron BJ, Nishimura RA, McKenna WJ, Rakowski H, Josephson ME, Kieval RS.
    Circulation; 1999 Jun 08; 99(22):2927-33. PubMed ID: 10359738
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Dual-chamber pacing in hypertrophic obstructive cardiomyopathy: a comparison of acute and chronic effects.
    Sakai Y, Kawakami Y, Hirota Y, Ito T, Shimada S, Tokaji Y, Suwa M, Kawamura K, Morimoto T, Nishimoto Y, Sasaki S.
    Jpn Circ J; 1999 Dec 08; 63(12):971-5. PubMed ID: 10614843
    [Abstract] [Full Text] [Related]

  • 17. Septal myotomy-myectomy and transcoronary septal alcohol ablation in hypertrophic obstructive cardiomyopathy. A comparison of clinical, haemodynamic and exercise outcomes.
    Firoozi S, Elliott PM, Sharma S, Murday A, Brecker SJ, Hamid MS, Sachdev B, Thaman R, McKenna WJ.
    Eur Heart J; 2002 Oct 08; 23(20):1617-24. PubMed ID: 12323162
    [Abstract] [Full Text] [Related]

  • 18. The importance of ventricular septal morphology in the effectiveness of dual chamber pacing in hypertrophic obstructive cardiomyopathy.
    Dimitrow PP, Grodecki J, Bacior B, Dudek D, Legutko J, Jaszcz KK, Dubiel JS.
    Pacing Clin Electrophysiol; 2000 Sep 08; 23(9):1324-9. PubMed ID: 11025886
    [Abstract] [Full Text] [Related]

  • 19. Electromechanical left ventricular behavior after nonsurgical septal reduction in patients with hypertrophic obstructive cardiomyopathy.
    Henein MY, O'Sullivan CA, Ramzy IS, Sigwart U, Gibson DG.
    J Am Coll Cardiol; 1999 Oct 08; 34(4):1117-22. PubMed ID: 10520800
    [Abstract] [Full Text] [Related]

  • 20. Long-term follow-up impact of dual-chamber pacing on patients with hypertrophic obstructive cardiomyopathy.
    Yue-Cheng H, Zuo-Cheng L, Xi-Ming L, Yuan DZ, Dong-Xia J, Ying-Yi Z, Hui-Ming Y, Hong-Liang C.
    Pacing Clin Electrophysiol; 2013 Jan 08; 36(1):86-93. PubMed ID: 23078085
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.